Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CDI Mediated Acylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100448849C details a safe CDI-mediated acylation method for 2-methylpiperazine, offering high regioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Discover a novel, non-Grignard synthesis for 1-cyclopropyl-2-(2-fluorophenyl) ethyl ketone. Enhanced safety, mild conditions, and scalable manufacturing for antithrombotic APIs.